Intelligent Bio Solutions Inc.
INBS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,112 | $844 | $729 | $607 |
| % Growth | 31.7% | 15.8% | 20% | – |
| Cost of Goods Sold | $594 | $508 | $387 | $384 |
| Gross Profit | $518 | $336 | $341 | $223 |
| % Margin | 46.6% | 39.8% | 46.8% | 36.7% |
| R&D Expenses | $0 | $1,456 | $358 | $507 |
| G&A Expenses | $0 | $1,163 | $0 | $1,809 |
| SG&A Expenses | $2,660 | $2,718 | $2,408 | $1,809 |
| Sales & Mktg Exp. | $0 | $1,555 | $0 | $0 |
| Other Operating Expenses | $858 | -$736 | $129 | $172 |
| Operating Expenses | $3,518 | $3,437 | $2,895 | $2,488 |
| Operating Income | -$3,000 | -$3,103 | -$2,553 | -$2,264 |
| % Margin | -269.8% | -367.7% | -350.3% | -372.8% |
| Other Income/Exp. Net | $17 | $13 | $3 | $8 |
| Pre-Tax Income | -$2,983 | -$3,090 | -$2,551 | -$2,257 |
| Tax Expense | $0 | $13 | $0 | $0 |
| Net Income | -$2,983 | -$3,090 | -$2,544 | -$2,249 |
| % Margin | -268.3% | -366.1% | -349% | -370.3% |
| EPS | -3.5 | -4.4 | -4.4 | -5 |
| % Growth | 20.5% | 0% | 12% | – |
| EPS Diluted | -3.5 | -4.4 | -4.4 | -5 |
| Weighted Avg Shares Out | 855 | 527 | 577 | 454 |
| Weighted Avg Shares Out Dil | 855 | 527 | 577 | 454 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $9 | $18 | $22 |
| Interest Expense | $4 | $10 | $15 | $14 |
| Depreciation & Amortization | $303 | $300 | $302 | $308 |
| EBITDA | -$2,676 | -$2,792 | -$2,234 | -$1,936 |
| % Margin | -240.7% | -330.9% | -306.5% | -318.6% |